PyInvesting

Market research

OMCL Omnicell Inc

NASDAQ USD Healthcare

Latest close

Loading market data…

Test a moving-average rule with historical data.

Market cap
2B
P/E ratio
42.36
Analyst target
57.8571
Dividend yield
Not available
Beta
0.97

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 4 months ago

Omnicell, Inc is currently in a long term uptrend where the price is trading 23.3% above its 200 day moving average.

From a valuation standpoint, the stock is 99.5% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 6.5.

Omnicell, Inc's total revenue rose by 0.4% to $249M since the same quarter in the previous year.

Its net income has dropped by 25.9% to $16M since the same quarter in the previous year.

Finally, its free cash flow grew by 225.1% to $65M since the same quarter in the previous year.

Based on the above factors, Omnicell, Inc gets an overall score of 4/5.